Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Jackson

Showing results (71-80 of 182) with videos related to

Pageof 19
Sort By:
Chest|April 11, 2020
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Grainne d'Ancona, Maria Elstad, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 24, 2021
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthmaAndrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 7, 2024
Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic AsthmaJessica Gates, Andrew Hearn, Tom Mason, et al.
Allergy|January 12, 2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthmaGrainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 20, 2026
Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: a post hoc analysisMichael E Wechsler, Arnaud Bourdin, Klaus F Rabe, et al.
Allergy|December 10, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthmaJoanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, et al.
ERJ Open Research|December 2, 2020
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitisAlexandra M Nanzer, Jaideep Dhariwal, Joanne Kavanagh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 10, 2021
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal SensitizationJaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Detection of Cardiac Involvement in Eosinophilic Granulomatosis With Polyangiitis (EGPA) With Multiparametric Cardiovascular Magnetic Resonance (CMR)Alina Hua, Agata Sularz, Peter Wheen, et al.
NPJ Primary Care Respiratory Medicine|April 14, 2025
Asthma control and opportunities to optimize management and the healthcare provider experience using the AsthmaOptimiser online tool in Dutch general practice: the CAPTURE studyMarika T Leving, Yoran H Gerritsma, David J Jackson, et al.
Pageof 19

Showing results (71-80 of 182) with videos related to

Sort By:
Pageof 19
Chest|April 11, 2020
Real-World Effectiveness and the Characteristics of a "Super-Responder" to Mepolizumab in Severe Eosinophilic AsthmaJoanne E Kavanagh, Grainne d'Ancona, Maria Elstad, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 24, 2021
The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthmaAndrew P Hearn, Joanne Kavanagh, Grainne d'Ancona, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 7, 2024
Long-Term Effectiveness of Anti-IL-4R Therapy Following Suboptimal Response to Anti-IL-5/5R Therapy in Severe Eosinophilic AsthmaJessica Gates, Andrew Hearn, Tom Mason, et al.
Allergy|January 12, 2021
Adherence to inhaled corticosteroids and clinical outcomes following a year of benralizumab therapy for severe eosinophilic asthmaGrainne d'Ancona, Joanne E Kavanagh, Jaideep Dhariwal, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 20, 2026
Dupilumab sustains efficacy despite LABA and ICS withdrawal in patients with asthma: a post hoc analysisMichael E Wechsler, Arnaud Bourdin, Klaus F Rabe, et al.
Allergy|December 10, 2020
Benralizumab after sub-optimal response to mepolizumab in severe eosinophilic asthmaJoanne E Kavanagh, Andrew P Hearn, Grainne d'Ancona, et al.
ERJ Open Research|December 2, 2020
Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitisAlexandra M Nanzer, Jaideep Dhariwal, Joanne Kavanagh, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 10, 2021
Real-World Effectiveness of Anti-IL-5/5R Therapy in Severe Atopic Eosinophilic Asthma with Fungal SensitizationJaideep Dhariwal, Andrew P Hearn, Joanne E Kavanagh, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Detection of Cardiac Involvement in Eosinophilic Granulomatosis With Polyangiitis (EGPA) With Multiparametric Cardiovascular Magnetic Resonance (CMR)Alina Hua, Agata Sularz, Peter Wheen, et al.
NPJ Primary Care Respiratory Medicine|April 14, 2025
Asthma control and opportunities to optimize management and the healthcare provider experience using the AsthmaOptimiser online tool in Dutch general practice: the CAPTURE studyMarika T Leving, Yoran H Gerritsma, David J Jackson, et al.
Pageof 19